- Home
- UEC vs KYMR Comparison
UEC vs KYMR Comparison
Compare UEC & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UEC
- KYMR
- Stock Information
- Founded
- UEC 2003
- KYMR 2015
- Country
- UEC United States
- KYMR United States
- Employees
- UEC N/A
- KYMR N/A
- Industry
- UEC Other Metals and Minerals
- KYMR Medicinal Chemicals and Botanical Products
- Sector
- UEC Basic Materials
- KYMR Health Care
- Exchange
- UEC Nasdaq
- KYMR Nasdaq
- Market Cap
- UEC 3.0B
- KYMR 2.6B
- IPO Year
- UEC N/A
- KYMR 2020
- Fundamental
- Price
- UEC $7.08
- KYMR $40.61
- Analyst Decision
- UEC Strong Buy
- KYMR Buy
- Analyst Count
- UEC 2
- KYMR 15
- Target Price
- UEC $10.63
- KYMR $55.60
- AVG Volume (30 Days)
- UEC 7.3M
- KYMR 532.1K
- Earning Date
- UEC 03-10-2025
- KYMR 02-20-2025
- Dividend Yield
- UEC N/A
- KYMR N/A
- EPS Growth
- UEC N/A
- KYMR N/A
- EPS
- UEC N/A
- KYMR N/A
- Revenue
- UEC $17,203,000.00
- KYMR $87,563,000.00
- Revenue This Year
- UEC $60,962.50
- KYMR N/A
- Revenue Next Year
- UEC $34.61
- KYMR $33.16
- P/E Ratio
- UEC N/A
- KYMR N/A
- Revenue Growth
- UEC N/A
- KYMR 86.92
- 52 Week Low
- UEC $4.06
- KYMR $26.92
- 52 Week High
- UEC $8.93
- KYMR $53.27
- Technical
- Relative Strength Index (RSI)
- UEC 45.20
- KYMR 47.90
- Support Level
- UEC $6.74
- KYMR $40.20
- Resistance Level
- UEC $7.90
- KYMR $44.34
- Average True Range (ATR)
- UEC 0.37
- KYMR 2.58
- MACD
- UEC -0.01
- KYMR 0.29
- Stochastic Oscillator
- UEC 31.82
- KYMR 57.47
About UEC Uranium Energy Corp.
Uranium Energy Corp is engaged in uranium mining and related activities. The company is working towards fueling the demand for carbon-free nuclear energy, a key solution to climate change, and energy source for the low-carbon future. The company is advancing its next generation of low-cost, environmentally friendly, in-situ recovery (ISR) mining uranium projects. The company has two extraction-ready ISR hub and spoke platforms in South Texas and Wyoming. UEC also has seven U.S. ISR uranium projects with all of their permits in place, with additional diversified holdings of uranium assets across the U.S., Canada and Paraguay.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.